TotalMarketCap

Precigen

PGENNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$1.497 B

$4.18 -17.41%

Close of 6 Nov 2026

As of 6 Nov 2026, Precigen (PGEN) has a market capitalization of $1.50B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$9.68M

#3139 by revenue

Earnings

-$250.6M

Loss-making

Shares outstanding

358,549,980

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #112NanobiotixNBTX$1.52B
  2. #113Nuvation BioNUVB$1.51B
  3. #114PrecigenPGEN$1.50B
  4. #115uniQureQURE$1.47B
  5. #116Pacira BioSciencesPCRX$1.45B

What if Precigen were worth as much as…

Open the what-if tool →

Gold $28.2T

$78,752.96

Per share 18,863× higher

Bitcoin $1.53T

$4,261.19

Per share 1,021× higher

Apple $5.02T

$13,989.08

Per share 3,351× higher

Or at a round number

$2.00B$5.00B$10.0B$20.0B

Where these numbers come from

Share counts and financials for Precigen are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.